GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $741,000 | -46.3% | 13,435 | -38.5% | 0.02% | -47.5% |
| Q2 2020 | $1,380,000 | +24.4% | 21,859 | +0.7% | 0.04% | -2.4% |
| Q1 2020 | $1,109,000 | -25.6% | 21,706 | +15.7% | 0.04% | +13.9% |
| Q4 2019 | $1,491,000 | +57.9% | 18,763 | -3.6% | 0.04% | +56.5% |
| Q3 2019 | $944,000 | -13.4% | 19,464 | -6.1% | 0.02% | -11.5% |
| Q2 2019 | $1,090,000 | – | 20,726 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |